Observational Study to Evaluate Allogeneic HSCT Outcomes for Cerebral Adrenoleukodystrophy (CALD)
Condition(s):X-Linked Adrenoleukodystrophy (X-ALD); Cerebral Adrenoleukodystrophy (CALD); Adrenoleukodystrophy (ALD)Last Updated:May 21, 2020Terminated
Hide Studies Not Open or Pending
Condition(s):X-Linked Adrenoleukodystrophy (X-ALD); Cerebral Adrenoleukodystrophy (CALD); Adrenoleukodystrophy (ALD)Last Updated:May 21, 2020Terminated
Condition(s):Cerebral Adrenoleukodystrophy (CALD); Adrenoleukodystrophy (ALD); X-Linked Adrenoleukodystrophy (X-ALD)Last Updated:February 7, 2024Active, not recruiting
Condition(s):Adrenomyeloneuropathy; AdrenoleukodystrophyLast Updated:March 2, 2012Terminated
Condition(s):Cerebral AdrenoleukodystrophyLast Updated:December 2, 2017Withdrawn
Condition(s):Adrenoleukodystrophy; Restless Legs SyndromeLast Updated:April 6, 2023Recruiting
Condition(s):Cerebral Adrenoleukodystrophy (CALD)Last Updated:September 11, 2023Completed
Condition(s):Cerebral Adrenoleukodystrophy (CALD)Last Updated:April 25, 2022Completed
Condition(s):Cerebral Adrenoleukodystrophy (cALD)Last Updated:March 13, 2024Recruiting
Condition(s):AdrenoleukodystrophyLast Updated:October 23, 2020Terminated
Condition(s):AdrenoleukodystrophyLast Updated:February 9, 2009Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.